The short answer
Cancer between 15 and 39 arrives during fertility, career and insurance transitions. The clinical gaps are documented; so is the isolation of being decades younger than everyone else.
NCI estimated 85,480 adolescents and young adults aged 15-39 would be diagnosed with cancer in the US in 2025, around 4.2% of all cases.
NCCN states fertility preservation should ideally be initiated before treatment starts; the decision window is often days, not weeks.
AYA enrolment in cancer clinical trials sits consistently below 10%, and is far lower at non-paediatric centres (12%) than paediatric ones (35%).
Patients aged 26 and over are much more likely to be uninsured or underinsured, and public or no insurance is associated with poorer survival.
Choose how you want to understand this
The full explanation.
Who this covers
Adolescents and young adults with cancer are defined as people aged 15 to 39 at first diagnosis, a grouping originally set by the NCI Progress Review Group and used in NCCN's guidelines. NCI estimated 85,480 such diagnoses in the United States in 2025, roughly 4.2% of all cancer cases. The most common types are breast, thyroid and testicular cancer and melanoma, alongside leukaemias, lymphomas, brain tumours and sarcomas. Overall five-year relative survival across the group is around 86%, new case rates rose by about 0.3% a year between 2013 and 2022, and death rates fell by about 0.9% a year between 2014 and 2023.
The gap
For a long period, survival improvements in this age band advanced more slowly than for children or older adults - the pattern usually called the AYA gap. Several contributors are documented. Cancer is not suspected in young people, so symptoms are attributed to something else and diagnosis is delayed. Patients fall between paediatric and adult services, which use different protocols for the same diseases. Some tumours behave differently in this age range. Enrolment in clinical trials is low: NCCN reports AYA participation consistently below 10%, with 35% at paediatric cancer centres compared with 12% at non-paediatric centres. And insurance status matters - NCCN notes that having public or no insurance is associated with poorer outcomes and that uninsured patients are less likely to enter trials.
Fertility, on a short clock
NCCN states that fertility preservation should ideally be initiated before the start of treatment. That places a consequential decision in the same week as diagnosis, often before the treatment plan is finalised. Sperm banking is quick and comparatively inexpensive. Oocyte or embryo cryopreservation generally requires around two weeks of ovarian stimulation, which has to be negotiated against the urgency of starting treatment. Ovarian tissue cryopreservation is an option in some circumstances.
The recurring complaint is that it was raised late or not at all. Raising it yourself at the first appointment, and asking for a referral to reproductive endocrinology even while undecided, protects the option. Where preservation before treatment was not possible, NCCN notes it may be appropriate to revisit later. Livestrong Fertility provides assistance with costs, which are frequently not covered by insurance.
Insurance, work and money
This age range coincides with the least stable period of most people's finances. NCCN records that patients aged 26 and over are much more likely to be uninsured or underinsured. Careers are interrupted at the point earnings are being established, student debt is often outstanding, and sick pay and disability cover are thinner for people early in employment or working freelance. NCCN recommends flexible scheduling of treatment dates and consultations so school or work can continue, plus referral to educational and career services and financial counselling. Asking for a financial navigator early is more useful than asking after the bills arrive.
The isolation
NCI states directly that young adults often experience isolation from friends and family who do not understand what they are going through, particularly during transitions like starting college or a career. The specifics recur: being the only person in the waiting room under sixty, and being asked whether you are there with a parent. Friends whose lives continue on schedule while yours stops. Deciding when to tell someone you are dating. Hair loss, surgical changes, weight change and early menopause arriving at an age when appearance carries particular weight. Fertility loss becoming permanent before the question of children was ever considered. Parents stepping back into a caregiving role, which is a relief and a regression at the same time.
Concrete routes
Ask whether the centre has an AYA-specific programme and request referral if it does; these teams exist to handle exactly the combination above. Ask which centre would give you access to more trials. Stupid Cancer and Teen Cancer America run peer communities for this age group, and CancerCare runs age-specific support groups. Survivorship care planning matters more here than at any other age, because the late effects of treatment have decades in which to appear.
Sources
- NCCN Clinical Practice Guidelines - Adolescent and Young Adult Oncology (JNCCN)
- NCI - Fertility issues in girls and women with cancer
- NCI - Fertility issues in boys and men with cancer
- Livestrong Fertility - Financial assistance for fertility preservation
- Stupid Cancer - Community for young adults affected by cancer
- Teen Cancer America
Words to know
Tap any term to see what it means.

Common questions
Who counts as an adolescent or young adult with cancer?
People aged 15 to 39 at first diagnosis, the definition used by the NCI Progress Review Group and adopted by NCCN. NCI estimated 85,480 such diagnoses in the United States in 2025, about 4.2% of all cancer cases.
When do I need to make a decision about fertility?
Usually immediately. NCCN states fertility preservation should ideally be initiated before treatment begins. Sperm banking can be done in days; oocyte or embryo cryopreservation typically requires around two weeks of ovarian stimulation. Raise it at the first appointment and ask for a referral to reproductive endocrinology even if you are undecided.
What if nobody mentioned fertility to me?
Ask directly and ask now. Discussions between clinicians and young patients have become more common but remain inconsistent. If treatment has already started, it is still worth raising - NCCN notes that where preservation before treatment was impractical, it may be appropriate to revisit it later.
Why does trial enrolment matter at this age?
Because low enrolment is one of the reasons progress in this age band lagged. NCCN reports AYA participation consistently below 10%, with 35% enrolment at paediatric cancer centres against 12% at non-paediatric centres. Asking which centre would give you access to more trials is a reasonable question.
Where do I find other people my age with cancer?
AYA-specific programmes at cancer centres are the main clinical route and can usually be requested by referral. Stupid Cancer and Teen Cancer America run peer communities and events for this age group, and CancerCare runs age-specific support groups.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the federal sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer Explained Editorial TeamSources last checked: 2026-07-30Last updated: 2026-07-30Next planned review: 2028-07-29
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
